122 results
8-K
EX-1.1
PRAX
Praxis Precision Medicines Inc
29 Mar 24
Other Events
4:30pm
or contemplated in the Registration Statement, the Time of Sale Prospectus and the Prospectus.
(i) Independent Accountants. Ernst & Young LLP, who has certified … Statement, the Time of Sale Prospectus and the Prospectus is an independent registered public accounting firm with respect to the Company and its
424B5
PRAX
Praxis Precision Medicines Inc
29 Mar 24
Prospectus supplement for primary offering
4:29pm
display its bid at a price not in excess of the highest independent bid of that security. However, if all independent bids are lowered below … ) for the year ended December 31, 2023, have been audited by Ernst & Young LLP, independent registered public accounting firm, as set forth in their report
424B5
PRAX
Praxis Precision Medicines Inc
27 Mar 24
Prospectus supplement for primary offering
4:49pm
and extending through the completion of distribution. A passive market maker must display its bid at a price not in excess of the highest independent bid … of that security. However, if all independent bids are lowered below the passive market maker’s bid, that bid must then be lowered when specified purchase
S-3
EX-4.4
PRAX
Praxis Precision Medicines Inc
5 Mar 24
Shelf registration
9:08am
or 8.4 which, in the opinion of a nationally recognized firm of independent certified public accountants or investment bank expressed in a written … one day before the due date of any payment of money, an amount in cash, sufficient, in the opinion of a nationally recognized firm of independent public
S-3
EX-23.2
0hjh0 ce7d
5 Mar 24
Shelf registration
9:08am
S-3
EX-1.2
5cejsiufj1
5 Mar 24
Shelf registration
9:08am
S-3
hio79m
5 Mar 24
Shelf registration
9:08am
S-8
uo5x kjccmo
5 Mar 24
Registration of securities for employees
7:33am
S-8
EX-23.1
xgzcw8cb
5 Mar 24
Registration of securities for employees
7:33am
8-K
n81oce
5 Mar 24
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
7:13am
8-K
EX-99.2
54iukx14e3puazhxu g6
5 Mar 24
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
7:13am
S-8
km4agr5imavdh ls4s
31 Jan 24
Registration of securities for employees
4:20pm
S-8
EX-23.1
m23nq lk7vf
31 Jan 24
Registration of securities for employees
4:20pm
S-8
EX-99.1
23f84f rlulj6rm0k7
31 Jan 24
Registration of securities for employees
4:20pm
8-K
EX-1.1
j7dz1h l2jm
12 Jan 24
Other Events
5:23pm